GK
RGEN icon

Graney & King’s Repligen RGEN Stock Holding History

Graney & King’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Hold
160
– – 0.01% 208
2026
Q1 		$18.9K Hold
160
– – 0.01% 206
2025
Q4 		$26.2K Hold
160
– – 0.02% 181
2025
Q3 		$21.4K Hold
160
– – 0.01% 186
2025
Q2 		$19.9K Hold
160
– – 0.01% 184
2025
Q1 		$20.4K Hold
160
– – 0.02% 178
2024
Q4 		$23K Buy
+160
New +$22.9K 0.02% 172

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Graney & King's RGEN Position: Q2 2026 in Review

Graney & King held its Repligen (RGEN) position steady in Q2 2026 at 160 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #208.

Graney & King first reported a position in RGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.2K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Graney & King held 160 shares of Repligen worth $21.8K as of Q2 2026.
  • Graney & King left its Repligen share count unchanged in Q2 2026.
  • Repligen made up 0.01% of Graney & King's portfolio in Q2 2026, its #208 holding.
  • Graney & King first reported a position in Repligen in Q4 2024 and has held it in 7 quarters since.
  • Graney & King's Repligen position peaked at $26.2K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.